ReportWire

Tag: stigma

  • Add This to the List of Long COVID Symptoms: Stigma

    Add This to the List of Long COVID Symptoms: Stigma

    [ad_1]

    Jan. 13, 2023 – People with long COVID may have dizziness, headaches, sleep problems, sluggish thinking, and many other problems. But they can also face another problem – stigma.

    Most people with long COVID find they’re facing stigma due to their condition, according to a new report from researchers in the United Kingdom. In short: Relatives and friends may not believe they’re truly sick.

    The U.K. team found that more than three-quarters of people studied had experienced stigma often or always. 

    In fact, 95% of people with long COVID faced at least one type of stigma at least sometimes, according to the study, published in November in the journal PLOS One

    Those conclusions had surprised the study’s lead researcher, Marija Pantelic, PhD, a public health lecturer at Brighton and Sussex Medical School.

    “After years of working on HIV-related stigma, I was shocked to see how many people were turning a blind eye to and dismissing the difficulties experienced by people with long COVID,” Pantelic says. “It has also been clear to me from the start that this stigma is detrimental not just for people’s dignity, but also public health.”

    Even some doctors argue that the growing attention paid to long COVID is excessive. 

    “It’s often normal to experience mild fatigue or weaknesses for weeks after being sick and inactive and not eating well. Calling these cases long COVID is the medicalization of modern life,” Marty Makary, MD, a surgeon and public policy researcher at the Johns Hopkins School of Medicine, wrote in a commentary in The Wall Street Journal

    Other doctors strongly disagree, including Alba Azola, MD, co-director of the Johns Hopkins Post-Acute COVID-19 Team and an expert in the stigma surrounding long COVID. 

    “Putting that spin on things, it’s just hurting people,” she says. 

    One example is people who cannot return to work.

    “A lot of their family members tell me that they’re being lazy,” Azola says. “That’s part of the public stigma, that these are people just trying to get out of work.” 

    Some experts say the U.K. study represents a landmark. 

    “When you have data like this on long COVID stigma, it becomes more difficult to deny its existence or address it,” says Naomi Torres-Mackie, PhD, a clinical psychologist at Lenox Hill Hospital in New York City. She also is head of research at the New York-based Mental Health Coalition, a group of experts working to end the stigma surrounding mental health.

    She recalls her first patient with long COVID.

    “She experienced the discomfort and pain itself, and then she had this crushing feeling that it wasn’t valid, or real. She felt very alone in it,” Torres-Mackie says. 

    Another one of her patients is working at her job from home but facing doubt about her condition from her employers.

    “Every month, her medical doctor has to produce a letter confirming her medical condition,” Torres-Mackie says.

    Taking part in the British stigma survey were 1,166 people, including 966 residents of the United Kingdom, with the average age of 48. Nearly 85% were female, and more than three-quarters were educated at the university level or higher.

    Half of them said they had a clinical diagnosis of long COVID.

    More than 60% of them said that at least some of the time, they were cautious about who they talked to about their condition. And fully 34% of those who did disclose their diagnosis said that they regretted having done so.

    That’s a difficult experience for those with long COVID, says Leonard Jason, PhD, a professor of psychology at DePaul University in Chicago.

    “It’s like they’re traumatized by the initial experience of being sick, and retraumatized by the response of others to them,” he says.

    Unexplained illnesses are not well-regarded by the general public, Jason says. 

    He gave the example of multiple sclerosis. Before the 1980s, those with MS were considered to have a psychological illness, he says. “Then, in the 1980s, there were biomarkers that said, ‘Here’s the evidence.’”

    The British study described three types of stigma stemming from the long COVID diagnosis of those questioned:

    • Enacted stigma: People were directly treated unfairly because of their condition.
    • Internalized stigma: People felt embarrassed by that condition.
    • Anticipated stigma: People expected they would be treated poorly because of their diagnosis.

    Azola calls the medical community a major problem when it comes to dealing with long COVID.

    “What I see with my patients is medical trauma,” she says. They may have symptoms that send them to the emergency room, and then the tests come back negative. “Instead of tracking the patients’ symptoms, patients get told, ‘Everything looks good, you can go home, this is a panic attack,’” she says.

    Some people go online to search for treatments, sometimes launching GoFundMe campaigns to raise money for unreliable treatments. 

    Long COVID patients may have gone through five to 10 doctors before they arrive for treatment with the Hopkins Post-Acute COVID-19 Team. The clinic began in April 2020 remotely and in August of that year in person.

    Today, the clinic staff spends an hour with a first-time long COVID patient, hearing their stories and helping relieve anxiety, Azola says. 

    The phenomenon of long COVID is similar to what patients have had with chronic fatigue syndrome, lupus, or fibromyalgia, where people have symptoms that are hard to explain, says Jennifer Chevinsky, MD, deputy public health officer for Riverside County, CA.

    “Stigma within medicine or health care is nothing new,” she says.

    In Chicago, Jason notes that the federal government’s decision to invest hundreds of millions of dollars in long COVID research “shows the government is helping destigmatize it.”

    Pantelic says she and her colleagues are continuing their research. 

    “We are interested in understanding the impacts of this stigma, and how to mitigate any adverse outcomes for patients and services,” she says.

    [ad_2]

    Source link

  • Inoperable Lung Cancer: Current Advances, News, and Trends

    Inoperable Lung Cancer: Current Advances, News, and Trends

    [ad_1]

    By Foster Lasley, MD, as told to Kara Mayer Robinson  

    If your lung cancer can’t be treated with surgery, it doesn’t mean there’s nothing you can do. 

    You may still have treatment options like radiation therapy and chemotherapy. Nonsurgical treatments can lead to good outcomes and they’re commonly used around the world today.

     

     

    What’s Inoperable Lung Cancer?

    Inoperable lung cancer is simply a tumor that surgery can’t treat, which could be because your cancer is in a difficult spot to reach, it’s spread outside your lungs, or you have other serious health conditions. 

    For example, if your lungs aren’t healthy enough in general, or you have a prior condition like heart disease, it can make surgery too risky.

    How Do You Treat Inoperable Lung Cancer?

    It’s up to you and your doctor to decide which options are best for you. Every person is different, so your best treatment plan is based on your specific needs. 

    Radiation, chemotherapy, targeted therapy, and immunotherapy can each be used to treat inoperable lung cancer. Your doctor may recommend one treatment or a combination of treatments.

    What Are the Latest Advances in Inoperable Lung Cancer?

    Lung cancer treatment continues to improve thanks to ongoing improvements in detection and treatment. 

    CT scans and other screening methods are becoming more and more capable of detecting tumors early on, when they’re more treatable. 

    Different combinations of radiation therapy, chemotherapy, targeted therapy, and immunotherapy are being tested in clinical trials to figure out the best order and period of time for each treatment. 

    Doctors are constantly reviewing the latest research to find tweaks to improve care.

    What’s Coming in the Near Future?

    There’s a lot of research in the works.

    Current and upcoming clinical trials are looking at:

    • How to tailor treatment to individual cancer types
    • How to treat higher numbers of metastatic sites
    • Improving detection of small sites of distant metastases so that they can be treated 

    Experts are also discussing how to handle metastases to the brain. Doctors have different opinions on the best approach.

    Exciting research is being done to look at the use of stereotactic body radiation therapy (SBRT)  in combination with checkpoint inhibitors. SBRT is a type of radiotherapy that uses 3D imaging to target tumors all over your body. Checkpoint inhibitors are a type of drug that blocks proteins found in some cancer cells. 

    Using checkpoint inhibitors combined with other treatment methods may allow doctors to better treat lung cancer without surgery. This is especially exciting for people with inoperable lung cancer. Clinical trials are still in the early phase I stage, but this could be a big development. 

    Another exciting new development is the increasing use of SBRT to decrease the amount of oligometastatic sites in your body, often in combination with other therapies.

    How Do Disparities in Health and Health Care Impact Inoperable Lung Cancer?

    Unfortunately, recent research shows racial disparities for minorities in how long they have to wait for cancer care. 

    Many wealthy communities in the U.S. have an abundance of medical resources at their disposal. They’re also more concentrated around major cities. 

    But this means lower income areas, which have more people of color, are comparatively underserved. When access is difficult, and a larger area with more people only has a few cancer care locations, this can create a bottleneck and longer wait times for care.

    To combat this, public and private practices must make an effort to establish sites in these lower income and rural areas so that they’re closer to underserved communities. 

    We work hard in my practice to make sure patients get the same care regardless of race, ethnicity, and background, in a way that’s personalized to their specific needs and health conditions.

    What Can You Do to Manage the Stigma of Lung Cancer and Other Mental Health Concerns?

    People may assume your cancer is self-inflicted due to smoking. But it can happen even if you’ve never smoked a cigarette. There are plenty of other factors that play a role, including your family history of lung cancer. 

    This stigma, along with the emotional challenges of having lung cancer, can take a toll on your mental health, which plays a big role in holistic care. 

    If you lose hope or feel like your quality of life is getting worse, it can have a negative effect on your emotional and physical health. This can lead to a lack of exercise and high levels of stress, which can harm your treatment process and outcomes. 

    To help with this, I recommend finding a support group in your area. There are more and more popping up across the nation. If you can’t find one locally, there are many online communities willing to help and provide resources during your treatment process. 

    It’s also a good idea to exercise, eat right, and try to live your life as normal. Doing so helps with positivity and overall happiness, which can stave off stress and depression. A positive outlook and can-do attitude go a long way in helping to achieve a better outcome.

    What’s the Outlook for Inoperable Lung Cancer?

    There’s still hope if your lung cancer is inoperable. Modern medicine has found ways to treat patients with inoperable lung cancer effectively, so it’s absolutely vital you keep hope, stay positive, and fight. 

    Every day, doctors around the world are conducting clinical trials to find new, better ways to treat inoperable lung cancer. The solution to your specific case could be right around the corner, so we all have to keep going to get there.

    [ad_2]

    Source link

  • Hep C: Should You Share Your Diagnosis?

    Hep C: Should You Share Your Diagnosis?

    [ad_1]

    Patient advocate Rick Nash sometimes wears a T-shirt that reads, “My pre-existing condition is hepatitis C.” (It is also known as hep C or HCV.) He uses it to jumpstart conversations about the disease.

    Nash thinks frank talk can help debunk myths and ease the stigma around hep C. But not everyone is ready or able to be so open. Whether to talk about your hep C diagnosis or not is up to you.

    If you want to tell others about your status, there are some tactics that could help make the conversation go better.

    Talking to an Intimate Partner

    It’s important to be patient and open to any questions your partner may have. It’s likely they’ll want to know how you got hep C and whether they could have it too.

    Such questions are natural. But often, they’re tough to answer.

    Paul Bolter, community outreach and education manager at the American Liver Foundation in New York, explains why.

    “There’s still a lot of stigma and shame around the disease. The first thing people think of is drug use or sexual transmission,” he says.

    Even Nash writes that talking about hep C can feel like “you’re revealing a deadly secret.”

    To get over the hurdles:

    Explain that hep C is a virus that spreads through contact with an infected person’s blood. IV drug use is one way, but there are others. They include:

    • Needle stick
    • Blood transfusion
    • Organ transplant before 1992

    Tattoo or body piercing equipment that’s not sterile can cause it too. Some people, like Nash, get the infection at birth.

    Tell them hep C rarely spreads through sex. It’s a little more likely if you have rough sex, anal sex, or sex during an outbreak of a sexually transmitted infection (STI).

    Discuss safer sex options, such as using a condom if you make love during a woman’s period or have sex that can cause bleeding.

    Encourage your partner to get tested. Angelica Bedrosian, MSW, a prevention and outreach coordinator at the Hepatitis Education Project (HEP) in Seattle, says most adults should get a hep C test at least once. Anyone who injects drugs should have a test every 6 months, about the time it takes to build up antibodies to the virus.

    “[Make sure they know] the test is simple and hep C is curable,” she says.

    Talking to Your Family

    Bedrosian says you don’t have to disclose your hep C status to your family unless you want to.

    She explains that on its own, living with someone who has hep C isn’t risky. You just need to take a few precautions. Don’t share personal items that might have blood on them, like razors, toothbrushes, and nail clippers. If you live with children, store these items out of reach.

    If you do decide to talk to your family:

    Explain that hep C virus spreads in different ways. You don’t have to say how you got it.

    Assure your family they can’t catch hep C from you, even if you hug, kiss, or share food or utensils.

    Tell them that hep C is curable. If caught at an early stage, hep C is curable about 98% of the time, says Robert Brown Jr., MD, chief of gastroenterology and hepatology at New York’s Weill Cornell Department of Medicine.

    Don’t be afraid to ask for your family’s love and support, as well.

    Hep C Communication Among Minorities

    African Americans and some native peoples have higher rates of hepatitis C than other groups. Yet too few know about the disease or get tested for it.

    Brown says there are several reasons for this.

    “Access to care is less and trust in the medical system is less,” he says. “Stigma is [also] a key problem. We need to reduce stigma to eliminate barriers to care.”

    In Brown’s view, “The solution is to have less stigma and then more people could talk about it.” This is the reverse of Nash’s belief that more talk leads to less stigma.

    Bedrosian falls somewhere in between. She thinks it works best if people learn how to talk about hep C. She points to HEP’s outreach programs. They include a peer-training model that describes how hep C spreads, how to prevent it, and how to educate others.

    “This is how educational messages are best received, and how taboo is dismantled little by little,” she says.

    [ad_2]

    Source link